STOCK TITAN

Redmile (NRIX) holds 10.7M shares — 9.9% including warrants

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Redmile Group, LLC reports beneficial ownership of 10,696,314 shares of Nurix Therapeutics common stock, representing 9.9% of the class. The count includes 3,664,406 shares issuable upon exercise of certain pre-funded warrants subject to a Beneficial Ownership Limitation of 9.99%. RedCo II Offshore SPV LLC is reported with 5,967,424 shares (5.6%) following an internal reorganization that moved holdings from RedCo II Master Fund, L.P., which now reports 0 shares. Shares outstanding were 103,405,813 as of April 1, 2026 per the company Form 10-Q; warrant issuable amounts are presented separately and are factored into the percentage calculations per the filing.

Positive

  • None.

Negative

  • None.

Insights

Redmile reports near-10% stake including exercisable pre-funded warrants; structure changed via internal SPV reorganization.

Redmile Group is disclosed as beneficial owner of 10,696,314 shares (reported as 9.9% ) of Nurix, counting 3,664,406 shares issuable under certain pre-funded warrants constrained by a 9.99% Beneficial Ownership Limitation. The filing documents an internal reorganization that moved holdings from RedCo II Master Fund to RedCo II Offshore SPV.

Timing and exercise mechanics are governed by the warrant terms and the stated Beneficial Ownership Limitation; cash‑flow treatment for exercises is not described in the excerpt. Subsequent filings would show any exercise notices or changes in percent ownership.

Redmile beneficial ownership 10,696,314 shares reported beneficial ownership as of 04/20/2026
Percentage of class (Redmile) 9.9% calculated using 103,405,813 shares outstanding as of <date>April 1, 2026</date> plus warrant issuable amounts
RedCo II SPV ownership 5,967,424 shares reported after internal reorganization on 04/20/2026
Shares outstanding used 103,405,813 shares reported outstanding as of <date>April 1, 2026</date> per company Form 10-Q
Warrants — Redmile funds 3,664,406 shares issuable pre-funded warrants held directly by Redmile-managed funds (included in Redmile percentage)
Warrants — RedCo II SPV 2,881,142 shares issuable pre-funded warrants held directly by RedCo II SPV (included in SPV percentage)
Beneficial Ownership Limitation 9.99% cap on exercise of warrants stated in the filing
Beneficial Ownership Limitation regulatory
"The "Beneficial Ownership Limitation" is 9.99% of the shares of Common Stock then issued and outstanding"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Pre-Funded Warrants financial
"shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants to purchase Common Stock"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Blocker regulatory
"Subject to the Beneficial Ownership Blocker... a holder shall not be entitled to exercise the Warrants"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
Schedule 13G/A regulatory
"Amendment No. 5 ) Nurix Therapeutics, Inc. Common Stock ... SCHEDULE 13G/A"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many Nurix (NRIX) shares does Redmile Group report owning?

Redmile Group reports beneficial ownership of 10,696,314 shares of Nurix common stock. This figure equals 9.9% of the class after including certain pre-funded warrants counted under the filing's calculation.

What stake does RedCo II Offshore SPV LLC hold in NRIX?

RedCo II Offshore SPV LLC is reported with 5,967,424 shares, representing 5.6% of the common stock. The filing states this position followed an internal reorganization from RedCo II Master Fund, L.P.

How did the internal reorganization affect RedCo II Master Fund for NRIX?

RedCo II Master Fund, L.P. contributed its Nurix securities pro rata to SPVs and ceased to have voting or dispositive power. As a result, RedCo II Master reports 0 shares and will be dissolved.

What role do the pre-funded warrants play in Redmile's reported percentage of NRIX?

The filing includes up to 3,664,406 shares issuable on certain pre-funded warrants in the percentage calculation. A Beneficial Ownership Limitation of 9.99% caps exercises that would exceed that threshold.

Which share count and date are used to calculate the percentages in the NRIX filing?

Percentages are based on 103,405,813 shares outstanding as of April 1, 2026, per the issuer's Form 10-Q, plus specified counts of shares issuable upon exercise of the warrants referenced in the filing.





67080M103

(CUSIP Number)
04/20/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") that are or may be deemed beneficially owned by Redmile Group, LLC ("Redmile"), including RedCo II Offshore SPV LLC ("RedCo II SPV"), is incorporated by reference herein. Percentage based on (i) 103,405,813 shares of Common Stock outstanding as of April 1, 2026, as reported by the Issuer in its Form 10-Q for the quarterly period ended February 28, 2026 filed with the Securities and Exchange Commission on April 8, 2026 (the "Form 10-Q") plus (ii) 3,664,406 shares of Common Stock issuable upon exercise of certain of the Pre-Funded Warrants to purchase Common Stock (the "Warrants") held directly by certain investment vehicles, including RedCo II SPV, managed by Redmile (the "Redmile Funds"), which due to the Beneficial Ownership Limitation (as defined in Item 4) is the maximum number of shares that could be issued to the Redmile Funds upon exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by Jeremy C. Green is incorporated by reference herein. Percentage based on (i) 103,405,813 shares of Common Stock outstanding as of April 1, 2026, as reported by the Issuer in its Form 10-Q plus (ii) 3,664,406 shares of Common Stock issuable upon exercise of certain of the Warrants held directly by the Redmile Funds, including RedCo II SPV, which due to the Beneficial Ownership Limitation (as defined in Item 4) is the maximum number of shares that could be issued to the Redmile Funds upon exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person: The information in Item 4 relating to the shares of Common Stock that are or may be deemed beneficially owned by RedCo II SPV is incorporated by reference herein. Percentage based on (i) 103,405,813 shares of Common Stock outstanding as of April 1, 2026, as reported by the Issuer in its Form 10-Q plus (ii) 2,881,142 shares of Common Stock issuable upon exercise of certain of the Warrants held directly by RedCo II SPV.


SCHEDULE 13G




Comment for Type of Reporting Person: Following the internal reorganization among certain Redmile Funds described in Item 4 below, RedCo II Master Fund, L.P. beneficially owned no shares of the Issuer's Common Stock.


SCHEDULE 13G



Redmile Group, LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member
Date:04/24/2026
Jeremy C. Green
Signature:/s/ Jeremy C. Green
Name/Title:Jeremy C. Green
Date:04/24/2026
RedCo II Offshore SPV LLC
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member of Redmile Group, LLC, its manager
Date:04/24/2026
RedCo II Master Fund, L.P.
Signature:/s/ Jeremy C. Green
Name/Title:Managing Member of RedCo II (GP), LLC, General Partner of RedCo II Master Fund, L.P.
Date:04/24/2026